Radiosynthesis, structural identification and in vitro tissue binding study of [18F]FNA-S-ACooP, a novel radiopeptide for targeted PET imaging of fatty acid binding protein 3
- PMID: 38393497
- PMCID: PMC10891031
- DOI: 10.1186/s41181-024-00245-3
Radiosynthesis, structural identification and in vitro tissue binding study of [18F]FNA-S-ACooP, a novel radiopeptide for targeted PET imaging of fatty acid binding protein 3
Abstract
Background: Fatty acid binding protein 3 (FABP3) is a target with clinical relevance and the peptide ligand ACooP has been identified for FABP3 targeting. ACooP is a linear decapeptide containing a free amino and thiol group, which provides opportunities for conjugation. This work is to develop methods for radiolabeling of ACooP with fluorine-18 (18F) for positron emission tomography (PET) applications, and evaluate the binding of the radiolabeled ACooP in human tumor tissue sections with high FABP3 expression.
Results: The prosthetic compound 6-[18F]fluoronicotinic acid 4-nitrophenyl ester was conveniently prepared with an on-resin 18F-fluorination in 29.9% radiochemical yield and 96.6% radiochemical purity. Interestingly, 6-[18F]fluoronicotinic acid 4-nitrophenyl ester conjugated to ACooP exclusively by S-acylation instead of the expected N-acylation, and the chemical identity of the product [18F]FNA-S-ACooP was confirmed. In the in vitro binding experiments, [18F]FNA-S-ACooP exhibited heterogeneous and high focal binding in malignant tissue sections, where we also observed abundant FABP3 positivity by immunofluorescence staining. Blocking study further confirmed the [18F]FNA-S-ACooP binding specificity.
Conclusions: FABP3 targeted ACooP peptide was successfully radiolabeled by S-acylation using 6-[18F]fluoronicotinic acid 4-nitrophenyl ester as the prosthetic compound. The tissue binding and blocking studies together with anti-FABP3 immunostaining confirmed [18F]FNA-S-ACooP binding specificity. Further preclinical studies of [18F]FNA-S-ACooP are warranted.
Keywords: ACooP; Autoradiography; Fatty acid binding protein 3; Fluorine-18; PET; Peptide; Peptide radiolabeling; S-acylation.
© 2024. The Author(s).
Conflict of interest statement
XGL is an Editorial Board member of EJNMMI Radiopharmacy and Chemistry. Other authors declare that they have no competing interests.
Figures





Similar articles
-
Switching the Chemoselectivity in the Preparation of [18F]FNA-N-CooP, a Free Thiol-Containing Peptide for Targeted Positron Emission Tomography Imaging of Fatty Acid Binding Protein 3.Mol Pharm. 2024 Aug 5;21(8):4147-4156. doi: 10.1021/acs.molpharmaceut.4c00546. Epub 2024 Jul 15. Mol Pharm. 2024. PMID: 39008899
-
Light up heart-type fatty acid binding protein (FABP3) with a novel fluorine-18 labelled selective FABP3 ligand.EJNMMI Res. 2024 Nov 14;14(1):107. doi: 10.1186/s13550-024-01175-6. EJNMMI Res. 2024. PMID: 39542944 Free PMC article.
-
Automated Synthesis of Fluorine-18 Labeled CXCR4 Ligand via the Conjugation with Nicotinic Acid N-Hydroxysuccinimide Ester (6-[18F]SFPy).Molecules. 2020 Aug 27;25(17):3924. doi: 10.3390/molecules25173924. Molecules. 2020. PMID: 32867358 Free PMC article.
-
Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.Nucl Med Biol. 2015 Feb;42(2):184-91. doi: 10.1016/j.nucmedbio.2014.10.006. Epub 2014 Oct 16. Nucl Med Biol. 2015. PMID: 25457456
-
One step radiosynthesis of 6-[(18)F]fluoronicotinic acid 2,3,5,6-tetrafluorophenyl ester ([(18)F]F-Py-TFP): a new prosthetic group for efficient labeling of biomolecules with fluorine-18.J Med Chem. 2010 Feb 25;53(4):1732-40. doi: 10.1021/jm9015813. J Med Chem. 2010. PMID: 20088512
Cited by
-
Rapid cleavage of 6-[18F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules.EJNMMI Radiopharm Chem. 2025 Jul 8;10(1):40. doi: 10.1186/s41181-025-00368-1. EJNMMI Radiopharm Chem. 2025. PMID: 40629197 Free PMC article.
-
Utilizing Monocarboxylate Transporter 1-Mediated Blood-Brain Barrier Penetration for Glioblastoma Positron Emission Tomography Imaging with 6-[18F]Fluoronicotinic Acid.Mol Pharm. 2025 Aug 4;22(8):4819-4830. doi: 10.1021/acs.molpharmaceut.5c00457. Epub 2025 Jul 3. Mol Pharm. 2025. PMID: 40610391 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous